Michelle Fransen Shares A Historical Review on Plasma-Derived Medicinal Products
Michelle Fransen, Director, Lead for Study Management at Plasma Protein Therapeutics Association (PPTA), shared on LinkedIn:
”I am thrilled to share that Dr. Toby Simon and I had our article, “Source plasma apheresis and plasma-derived medicinal products: a historical review” published in the most recent issue Annals of Blood.
This paper, which can be found here, outlines the history of plasmapheresis and PDMP manufacturing which spans more than a century of scientific and clinical innovation.
We believe that understanding this history is more than academic—it underscores how continued innovation, strong regulatory oversight, and a focus on donor health are essential to sustaining a global plasma supply and advancing care for patients with immune deficiencies, coagulation disorders, and other rare diseases.”
Read the full article here.
Article: Source plasma apheresis and plasma-derived medicinal products: a historical review
Authors: Michelle Fransen, Toby Simon
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 27, 2026, 05:58Cedric Hermans: An Evening of Cinema in Support of Blood Disorder Research
-
Oct 27, 2026, 04:56Ayodeji Olayanju: Why Choose between a Transfusion and Haemoglobinopathy CPD When You Can Do Both?
-
Oct 27, 2026, 04:54Aisha Suala: When One Underfilled Tube Can Mislead the Entire Laboratory Result
-
Oct 27, 2026, 04:34Incremental Mobility and Venous Thromboembolism Risk in Hospitalized Medical Patients – JTH
-
Oct 27, 2026, 04:29Matthew Hazell: From Rare Blood to AI – Reflecting on Three Days of Innovation at AABB 2026
-
Oct 27, 2026, 04:24Khairul Missa Mohd Amin: Highlights from RANZCR ASM 2026 and Building Stronger PE Care
-
Oct 27, 2026, 04:14Pedro Perez: Why the Future of PE Care Demands Individualized Strategy
-
Oct 27, 2026, 04:09Hari Trivedi: Real-World AI Performance in PE Detection
-
Oct 27, 2026, 03:50Nathalie Conrad: Uncovering 30-Year Sex Differences Across 55 ESC Nations